Silver Spring, MD, United States of America

Kenneth E Kinnamon


Average Co-Inventor Count = 1.4

ph-index = 2

Forward Citations = 23(Granted Patents)


Location History:

  • Silver Spring, MD (US) (1980)
  • Rockville, MD (US) (1994)

Company Filing History:


Years Active: 1980-1994

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Kenneth E Kinnamon

Introduction

Kenneth E Kinnamon is a notable inventor based in Silver Spring, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating various diseases. With a total of 3 patents, Kinnamon's work has had a meaningful impact on medical science.

Latest Patents

Kinnamon's latest patents include innovative compounds such as heterocyclic and aromatic thiosemicarbazones, which are useful in the treatment of filariasis in humans and animals. This invention focuses on the therapeutic potential of these compounds in combating filariasis. Another significant patent involves anti-leishmanial lepidine derivatives, which are designed to improve chemotherapy for leishmaniasis. These derivatives feature a basic sidechain attachment that enhances their effectiveness, allowing for both parenteral and oral administration to infected animals.

Career Highlights

Kenneth E Kinnamon is currently associated with the US Government as represented by the Secretary of the Army. His work in this capacity has allowed him to contribute to important research and development projects aimed at addressing public health challenges.

Collaborations

Kinnamon has collaborated with esteemed colleagues such as John W McCall and Daniel L Klayman. These partnerships have facilitated the advancement of his research and the successful development of his patented inventions.

Conclusion

Kenneth E Kinnamon's innovative work in pharmaceuticals demonstrates his commitment to improving health outcomes through scientific research. His contributions continue to influence the field and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…